Pacer Advisors’s HUMANIGEN, INC. HGEN Stock Holding History

Pacer Advisors’s Portfolio HGEN Stock Details HGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-4,850	Closed	-$93K	–	1587
2021 Q1	$93K	Buy	+4,850	New	+$88.5K	﹤0.01%	1305

Other funds holding HGEN

VCM

Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Think Investments San Francisco, California $762M AUM 33.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Pacer Advisors's HGEN Position: Q2 2021 in Review

Pacer Advisors sold out of HUMANIGEN, INC. (HGEN) in Q2 2021, closing a stake of 4,850 shares — an estimated $93K sold.

Pacer Advisors first reported a position in HGEN in Q1 2021 and held it in 1 quarter. The position peaked at $93K in Q1 2021. 92 funds tracked by Wall St. Rank hold HGEN as of Q2 2021.

Pacer Advisors reported no remaining HUMANIGEN, INC. position as of Q2 2021 after selling out during the quarter.
Pacer Advisors sold 4,850 HUMANIGEN, INC. shares in Q2 2021, an estimated $93K.
Pacer Advisors first reported a position in HUMANIGEN, INC. in Q1 2021 and held it in 1 quarter.
Pacer Advisors's HUMANIGEN, INC. position peaked at $93K in Q1 2021.
92 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q2 2021.

Based on Pacer Advisors's 13F filing for Q2 2021, filed 21 Jul 2021.